Pharmaceuticals
Australia’s Pharmaceutical Benefits Scheme pays too much for prescription drugs. The Government’s purchasing policy needs to be much tougher on manufacturers and much fairer for consumers. It is not just a matter of saving money: nearly one in 10 Australians doesn’t take medicines a doctor prescribes because of cost.
Reports
-
28 October 2018
State Orange Book 2018: Policy priorities for states and territories -
5 March 2017
Cutting a better drug deal -
14 June 2016
Orange Book 2016: priorities for the next Commonwealth Government -
21 June 2015
Premium policy? Getting better value from the PBS -
1 December 2013
Poor pricing progress: price disclosure isn’t the answer to high drug prices
News & Opinion
-
25 March 2019
A mixed model is best for pharmacist prescribing -
24 July 2018
Queensland needs to cut pharmacy red tape -
8 May 2018
Turnbull government backs pharmacies over consumers, yet again -
25 October 2017
Pharmacy red tape should be cut: submission to Senate Select Committee -
11 May 2017
Canada should take health care lessons from Australia
Speeches & Events
-
13 November 2018
State Orange Book 2018: Policy priorities for states and territories – Melbourne -
20 March 2013
Ending Australia’s bad drug deal: the three elements of pharmaceutical pricing reform